Allopurinol is not associated with improving biomarkers of kidney damage in patients with asymptomatic hyperuricemia and stage 3 chronic kidney disease, according to a published post-hoc analysis.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
